Immunization and vaccines related implementation research advisory committee (IVIR-AC) - March 2021

1 – 5 March 2021
  • Session 1a: COVID-19 vaccine modelling
  • Session 1b: Optimizing COVID-19 vaccine costing
  • Session 2: Measles Case Fatality Ratio (CFR) estimation
  • Session 3: Overview of Vaccine Impact Modelling Consortium (VIMC)
  • Session 4: Meta-analysis of Economic Evaluations
  • Session 5: Full Public Health Value of Vaccines (FPHVV) - Influenza Vaccine
  • Session 6: IA 2030 Costing
  • Ad hoc session (February 2021): IA 2030 vaccine impact estimates 

Meeting materials

Meeting report

Related

Background materials

IVIR-AC Pink Book March 2021 
(download file and open in PDF viewer for access to full content)